Bandelarata Bollostresa OÜ

Active Registry code 14472990 OÜ Tallinn Registered 19 Apr 2018

Bandelarata Bollostresa OÜ is a OÜ based in Tallinn, registry code 14472990, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €86 608 with employees.

Turnover

86 608 €

↓ 43.3% vs Q2 2026

State taxes

8 199 €

↓ 31.4% vs Q2 2026

Labour taxes

4 256 €

↓ 33.2% vs Q2 2026

Employees

—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Retail trade · EMTAK 47

Turnover · Q3 2026 86 608 €

above 74% of companies

industry median 23 662 € · companies in the industry: 7 653
Revenue · 2025 556 768 €

above 90% of companies

industry median 16 974 € · companies in the industry: 13 500
Net profit margin · 2025 -2.8 %

above 28% of companies

industry median 1.3 % · companies in the industry: 9 480

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € thousand Q3 2026: 86 608 € · −43.3% vs Q2 2026 · industry median 23 662 € · above 74% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q2 2026: 2 124 € · −12.9% vs Q1 2026 · industry median 1 131 € · above 80% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q2 2026: 3 · +0.0% vs Q1 2026

State taxes, € Q3 2026: 8 199 € · −31.4% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	86 608	8 199	4 256	—
Q2 2026	152 806	11 951	6 373	3
Q1 2026	150 701	7 394	7 318	3
Q4 2025	50 850	11 681	8 543	3
Q3 2025	171 441	13 523	8 201	3
Q2 2025	170 493	9 553	8 763	3
Q1 2025	184 101	13 051	9 549	3
Q4 2024	193 431	10 845	8 679	3
Q3 2024	189 233	10 078	8 847	3
Q2 2024	195 172	9 451	7 241	3
Q1 2024	202 800	9 242	8 013	3
Q4 2023	197 412	11 490	7 689	3
Q3 2023	190 452	8 147	7 487	3
Q2 2023	180 404	8 610	7 440	3
Q1 2023	198 450	8 240	6 993	3
Q4 2022	194 660	9 792	6 606	3
Q3 2022	182 109	10 517	8 089	3
Q2 2022	165 554	8 805	8 133	3
Q1 2022	176 529	10 958	8 033	3

Financials by year

2018 – 2025

Revenue, € thousand 2025: 556 768 € · −28.4% vs 2024 · industry median 16 974 € · above 90% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -15 792 € · −35.4% vs 2024 · industry median 0 € · above 8% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -2.8 % · −1.3 pp vs the year before · industry median 1.3 % · above 28% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 163 868 € · +12.2% vs 2024

Equity, € 2025: -13 290 € · −631.2% vs 2024

Employees 2025: 3 · −25.0% vs 2024 · industry median 2 · above 70% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	556 768	-15 792	75 230	163 868	-13 290	3
2024	777 561	-11 662	82 980	146 081	2 502	4
2023	767 904	2 414	74 739	171 642	14 164	4
2022	728 590	-574	71 264	162 755	11 750	4
2021	651 192	4 476	79 398	150 556	12 325	4
2020	645 563	-451	78 780	142 458	7 849	4
2019	610 588	-4 278	85 547	129 834	8 300	4
2018	—	—	—	—	—	3

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

-2.8 %

Net profit / revenue

Return on assets (ROA)

-9.6 %

Net profit / assets

Equity ratio

-8.1 %

Equity / assets

Debt ratio

108.1 %

Liabilities / assets

Current ratio

0.91

Current assets / current liabilities

Revenue per employee

185 589 €

Revenue / average full-time employees

Labour cost per employee per month

2 090 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	22 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	27 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	29 Jul 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	30 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	14 Sep 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	29 Jul 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	30 Sep 2020	Company’s own	e-Äriregister

Board

Nasdaq CSD SE
Keeper of the share register · since 23 May 2018

Owners

Omanikukonto: LEGALEXPERT OÜ
Legal person · 10689505 · 2 500 €

100%

Beneficial owners

Sevim Zonguldak
Right to appoint or remove most of the management · TUR · since 31 Aug 2026

Founders and other persons

Katre Pall
Founder · 2 500 € · 18 Apr 2018

Activities (EMTAK)

47731Retail sale of pharmaceutical products Main

Rulings 7

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 50092512 / 5 23 Sep 2026	Entry made by the register on its own initiative		In force 23 Sep 2026	PDF
Ä 50092512 / M2 2 Sep 2026	Procedural ruling	16 Sep 2026	In force 2 Sep 2026	PDF
Ä 50092512 / 4 31 Aug 2026	Amendment entry		In force 31 Aug 2026	PDF
Ä 50092512 / 3 25 Aug 2026	Amendment entry		In force 25 Aug 2026	PDF
Ä 50092512 / M1 13 Jul 2024	Warning of deletion from the register: annual report not filed	16 Oct 2024	Deficiencies eliminated 30 Jul 2024	PDF
Ä 50092512 / 2 23 May 2018	Amendment entry		In force 23 May 2018	PDF
Ä 50092512 19 Apr 2018	First entry		In force 19 Apr 2018	PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data